Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sensors for Medicine and Technology gets funds for implanted home glucose monitor

This article was originally published in Clinica

Executive Summary

US company SMSI (Sensors for Medicine and Technology) has received a $15m venture capital cash injection to fund clinical trials of its novel glucose sensor technology. The Germantown, Maryland company is currently overseeing late preclinical stage development of the continuous monitoring device, and expects to file an investigational device exemption (IDE) for it in 2006. "The process to commercialisation should take another two years or so," president and CEO Marc Schneebaum told Clinica, adding that the trials are designed to demonstrate that the system is accurate enough to replace standard home blood glucose monitoring.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT057949

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel